Regional Blocks of Gynecological Surgeries

August 27, 2021 updated by: Reham Ali Abdelhaleem Abdelrahman, Cairo University

Comparison of Dural Puncture Epidural Technique Versus Conventional Epidural Technique for Adequate Anesthesia During Vaginal Surgeries

This study will be conducted on 273 patients of ASA grade I and II aged from 25 to 55 years and presented for elective vaginal surgeries such as vaginal hysterectomy, repair of prolapse Patients will be divided into three equal groups; group A control group for conventional epidural technique(n=91), group B for dural puncture epidural with 27G pencil point Whitacre spinal needle (n=91) and group C for dural puncture epidural with 25G pencil point Whitacre spinal needle(n=91). Randomization will be done using computer generated number and concealed using sequentially numbered sealed opaque envelope.

Study Overview

Study Type

Interventional

Enrollment (Actual)

273

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11562
        • Department of Anesthesia, Surgical ICU, and Pain Management
      • Cairo, Egypt, 11562
        • Reham Ali Abdelrahman

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • ASA I and II
  • Height(150-170 cm)

Exclusion Criteria:

  • patient refusal
  • hypersensitivity to local anesthetic drugs
  • bleeding disorders and coagulopathy(platelets count less than 80000,INR less than 1.5 or therapeutic dose of anticoagulant).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Conventional Epidural Technique
Procedure: Standard Lumbar Epidural Block using Touhy Epidural Needle (18G) at L4-5 inter-space and Epidural Catheter (20G) was inserted then bupivacaine 0.5% 15-20 ml with 50ug fentanyl was given.
25G Dural Puncture Epidural Technique at L4-5 inter-space using 0.5%Bupivacaine and Fentanyl.
27G Dural Puncture Epidural Technique at L4-5 inter-space using 0.5%Bupivacaine and Fentanyl.
Active Comparator: Dural Puncture Epidural Technique using pencil-point 25G Whitacre needle
Procedure: 25G Dural Puncture Epidural Block at L4-5 inter-space then bupivacaine 0.5% 15-20 ml with 50ug fentanyl was given.
27G Dural Puncture Epidural Technique at L4-5 inter-space using 0.5%Bupivacaine and Fentanyl.
Standard Lumbar Epidural Technique at L4-5 inter-space using 0.5%Bupivacaine and Fentanyl.
Active Comparator: Dural Puncture Epidural Technique using pencil-point 27G Whitacre needle
Procedure: 27G Dural Puncture Epidural Block at L4-5 inter-space then bupivacaine 0.5% 15-20 ml with 50ug fentanyl was given.
25G Dural Puncture Epidural Technique at L4-5 inter-space using 0.5%Bupivacaine and Fentanyl.
Standard Lumbar Epidural Technique at L4-5 inter-space using 0.5%Bupivacaine and Fentanyl.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
incidence of bilateral sacral blockade
Time Frame: Up to 30 minutes after local anesthetic injection
Sensory blockade was evaluated using a non-traumatic pinprick stimulus starting at the S2 dermatome and moving in a caudad direction (measured every 2 minutes)
Up to 30 minutes after local anesthetic injection

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Onset of sensory blockade
Time Frame: Up to 30 minutes after local anesthetic injection
Up to 30 minutes after local anesthetic injection
Maximum achieved sensory level
Time Frame: Up to 30 minutes after local anesthetic injection
Up to 30 minutes after local anesthetic injection
Time to achieve the maximum sensory level
Time Frame: Up to 30 minutes after local anesthetic injection
Up to 30 minutes after local anesthetic injection
Onset of motor blockade
Time Frame: Up to 30 minutes after local anesthetic injection
Up to 30 minutes after local anesthetic injection
Time to complete motor block
Time Frame: Up to 30 minutes after local anesthetic injection
Up to 30 minutes after local anesthetic injection
Duration of sensory block
Time Frame: Assessed every 20 minutes after achieving highest dermatome level of sensory analgesia
Time to two segmental dermatomes regression
Assessed every 20 minutes after achieving highest dermatome level of sensory analgesia
Duration of motor block
Time Frame: Assessed every 20 minutes after achieving Bromage 3 motor block
Time interval from achievement of Bromage 1 to regression of motor blockade to Bromage 1
Assessed every 20 minutes after achieving Bromage 3 motor block
Duration of analgesia
Time Frame: Time for requirement for rescue analgesia or VAS pain score >3 as postoperatively
Time from onset of sensory block to first complain of pain postoperatively as the epidural catheter will be removed after the surgery finished
Time for requirement for rescue analgesia or VAS pain score >3 as postoperatively
Number of epidural top-ups
Time Frame: Number of extra doses of local anesthetic given after injection of local anesthetic loading dose till end of the surgery
Number of extra doses of local anesthetic given after injection of local anesthetic loading dose till end of the surgery
Sedation score
Time Frame: Assessed every 20 minutes during the surgical procedure and postoperatively
Assessed every 20 minutes during the surgical procedure and postoperatively
Hemodynamic parameters
Time Frame: Assessed every 5 minutes from the start of anesthetic procedures till transfer the patients to the rooms
Assessed every 5 minutes from the start of anesthetic procedures till transfer the patients to the rooms
Perioperative side effects
Time Frame: During surgical period up to 7 days post-operatively
During surgical period up to 7 days post-operatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Reham Ali Abdelrahman, M.D., Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2019

Primary Completion (Actual)

June 28, 2021

Study Completion (Actual)

July 31, 2021

Study Registration Dates

First Submitted

December 23, 2018

First Submitted That Met QC Criteria

December 31, 2018

First Posted (Actual)

January 2, 2019

Study Record Updates

Last Update Posted (Actual)

September 1, 2021

Last Update Submitted That Met QC Criteria

August 27, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gynecologic Disease Requiring Vaginal Operation Under Neuraxial Anesthesia

Clinical Trials on 25G Dural Puncture Epidural Technique

3
Subscribe